UnitedHealth Group, Eli Lilly and Company, Hims & Hers Health, Abbott Laboratories, Walmart, Elevance Health, and Thermo Fisher Scientific are the seven Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are publicly traded shares of companies in the healthcare sector, including pharmaceutical firms, biotechnology developers, medical device manufacturers, and healthcare service providers. These stocks let investors participate in medical innovation and industry growth but carry risks tied to regulatory approvals, clinical trial results, and shifting healthcare policies. These companies had the highest dollar trading volume of any Medical stocks within the last several days.
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
NYSE:UNH traded up $0.29 during trading hours on Monday, reaching $282.94. 5,883,341 shares of the stock were exchanged, compared to its average volume of 7,813,306. The stock has a market capitalization of $256.66 billion, a P/E ratio of 11.86, a P/E/G ratio of 1.38 and a beta of 0.45. UnitedHealth Group has a 52 week low of $248.88 and a 52 week high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The firm has a 50 day simple moving average of $304.47 and a 200-day simple moving average of $432.39.
Read Our Latest Research Report on UNH
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
Shares of LLY stock traded down $5.54 during mid-day trading on Monday, hitting $766.17. 1,656,650 shares of the stock traded hands, compared to its average volume of 3,656,851. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.06 and a current ratio of 1.37. The firm has a market cap of $726.13 billion, a price-to-earnings ratio of 62.32, a price-to-earnings-growth ratio of 1.12 and a beta of 0.40. The company's 50-day simple moving average is $767.03 and its 200-day simple moving average is $800.17. Eli Lilly and Company has a twelve month low of $677.09 and a twelve month high of $972.53.
Read Our Latest Research Report on LLY
Hims & Hers Health (HIMS)
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
HIMS traded down $1.76 during trading on Monday, reaching $48.62. 16,011,275 shares of the stock traded hands, compared to its average volume of 24,175,895. The stock has a market cap of $10.88 billion, a price-to-earnings ratio of 70.53, a price-to-earnings-growth ratio of 1.85 and a beta of 2.02. Hims & Hers Health has a fifty-two week low of $13.47 and a fifty-two week high of $72.98. The stock's 50-day simple moving average is $53.82 and its two-hundred day simple moving average is $42.04.
Read Our Latest Research Report on HIMS
Abbott Laboratories (ABT)
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.
ABT traded up $1.20 on Monday, hitting $124.87. 5,788,082 shares of the stock traded hands, compared to its average volume of 6,224,577. The company has a current ratio of 1.78, a quick ratio of 1.27 and a debt-to-equity ratio of 0.26. The business has a fifty day moving average price of $132.98 and a two-hundred day moving average price of $129.68. The firm has a market capitalization of $217.25 billion, a PE ratio of 15.67, a P/E/G ratio of 2.35 and a beta of 0.73. Abbott Laboratories has a 52 week low of $99.92 and a 52 week high of $141.23.
Read Our Latest Research Report on ABT
Walmart (WMT)
Walmart Inc. engages in the operation of retail, wholesale, other units, and eCommerce worldwide. The company operates through three segments: Walmart U.S., Walmart International, and Sam's Club. It operates supercenters, supermarkets, hypermarkets, warehouse clubs, cash and carry stores, and discount stores under Walmart and Walmart Neighborhood Market brands; membership-only warehouse clubs; ecommerce websites, such as walmart.com.mx, walmart.ca, flipkart.com, PhonePe and other sites; and mobile commerce applications.
NYSE:WMT traded up $0.96 during trading hours on Monday, hitting $96.01. 5,790,288 shares of the stock were exchanged, compared to its average volume of 18,108,789. The company's 50 day moving average is $96.81 and its two-hundred day moving average is $94.68. The company has a market capitalization of $766.19 billion, a P/E ratio of 41.03, a price-to-earnings-growth ratio of 4.57 and a beta of 0.68. Walmart has a twelve month low of $66.67 and a twelve month high of $105.30. The company has a quick ratio of 0.22, a current ratio of 0.78 and a debt-to-equity ratio of 0.47.
Read Our Latest Research Report on WMT
Elevance Health (ELV)
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
NYSE:ELV traded up $2.66 during mid-day trading on Monday, hitting $279.75. The stock had a trading volume of 1,804,293 shares, compared to its average volume of 1,673,748. The stock has a market cap of $62.99 billion, a price-to-earnings ratio of 11.87, a PEG ratio of 0.81 and a beta of 0.60. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.44 and a current ratio of 1.44. Elevance Health has a twelve month low of $274.60 and a twelve month high of $567.26. The company's 50 day simple moving average is $371.52 and its 200 day simple moving average is $396.02.
Read Our Latest Research Report on ELV
Thermo Fisher Scientific (TMO)
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Thermo Fisher Scientific stock traded down $4.56 during trading hours on Monday, hitting $410.19. The company had a trading volume of 1,224,622 shares, compared to its average volume of 2,020,065. The firm has a market cap of $154.84 billion, a PE ratio of 24.09, a PEG ratio of 2.21 and a beta of 0.77. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.77 and a quick ratio of 1.38. Thermo Fisher Scientific has a one year low of $385.46 and a one year high of $627.88. The firm has a 50-day moving average of $410.38 and a 200 day moving average of $472.32.
Read Our Latest Research Report on TMO
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
